Related Experiment Video
Updated: Jan 5, 2026

In Vitro Analysis of E3 Ubiquitin Ligase Function
Published on: May 14, 2021
HECT-Type E3 Ubiquitin Ligases in Cancer
Francesca Bernassola1, Giovanni Chillemi2, Gerry Melino3
1Department of Experimental Medicine, TOR, University of Rome 'Tor Vergata', Rome 00133, Italy.
Abstract:
Ubiquitination, a post-translational modification that involves a covalent attachment of ubiquitin to a protein substrate, is essential for cellular homeostatic maintenance. At the end of a three-enzyme cascade, E3 ubiquitin ligases (E3s) recruit substrates and promote or directly catalyze ubiquitin transfer to targets. These enzymes largely determine the specificity of the ubiquitination reaction. Genetic alteration, abnormal expression, or dysfunction of E3s account for the occurrence and progression of human cancers. Indeed, excessive degradation of relevant tumor-suppressor molecules and impaired disposal of oncogenic proteins have been linked to tumorigenesis. This review focuses on the emerging roles of HECT-type E3s in tumorigenesis, and emphasizes how perturbations of these enzymes contribute to cancer pathogenesis.
Insights
Ubiquitination is vital for cell health. This review explores how HECT-type E3 ligases (E3s) impact cancer development when their function is altered.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Ubiquitination is a key post-translational modification regulating protein homeostasis.
- E3 ubiquitin ligases (E3s) are crucial enzymes that confer specificity to ubiquitination.
- Dysregulation of E3s is implicated in various human diseases, including cancer.
Purpose of the Study:
- To review the emerging roles of HECT-type E3 ubiquitin ligases in tumorigenesis.
- To highlight the contribution of HECT-type E3 perturbations to cancer pathogenesis.
Main Methods:
- Literature review focusing on HECT-type E3 ligases and their involvement in cancer.
- Analysis of existing research on the mechanisms linking E3 dysfunction to cancer development.
Main Results:
- HECT-type E3s play significant roles in regulating proteins involved in cell cycle, DNA repair, and signaling pathways critical for cancer.
- Altered expression or mutations in HECT-type E3s can lead to the destabilization of tumor suppressors or stabilization of oncoproteins.
- Specific HECT-type E3s have been identified as potential drivers or suppressors in various cancer types.
Conclusions:
- HECT-type E3 ligases are critical regulators in cancer pathogenesis.
- Understanding the specific roles of HECT-type E3s in tumorigenesis offers potential therapeutic targets for cancer treatment.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

